Original Article
International Journal of Obesity (2006) 30, 430–438. doi:10.1038/sj.ijo.0803076; published online 20 September 2005
Abnormalities of the somatotrophic axis in the obese agouti mouse
N M Martin1, P A Houston2, M Patterson1, A Sajedi1, D F Carmignac3, M A Ghatei1, S R Bloom1 and C J Small1
- 1Department of Metabolic Medicine, Imperial College at Hammersmith Campus, London, UK
- 2Department of Molecular and Cellular Neuroscience, Division of Neuroendoscience and Psychological Medicine, Imperial College at Hammersmith Campus, London, UK
- 3Division of Molecular Neuroendocrinology, National Institute for Medical Research, The Ridgeway, Mill Hill, London, UK
Correspondence: Professor SR Bloom, Department of Metabolic Medicine, Imperial College at Hammersmith Campus, Du Cane Road, London W12 0NN, UK. E-mail: s.bloom@imperial.ac.uk
Received 13 April 2005; Accepted 17 July 2005; Published online 20 September 2005.
Abstract
Objective:
Abnormalities of the melanocortin system produce obesity and increased linear growth. While the obesity phenotype is well characterised, the mechanism responsible for increased linear growth is unclear. The somatotrophic axis was studied in the obese agouti (Ay/a) mouse as a model of a perturbed melanocortin system.
Design:
Adult obese Ay/a mice were compared to age- and sex-matched wild-type (WT) controls. Weight and body length (nose–anus) were recorded. Plasma growth hormone (GH), insulin-like growth factor-I (IGFI), insulin and leptin were measured using radioimmunoassay. Since ghrelin is a potent GH secretagogue, plasma ghrelin, stomach ghrelin peptide and stomach ghrelin mRNA expression were studied. Hypothalamic periventricular (PeVN) somatostatin neurones and arcuate (Arc) neuropeptide Y (NPY) neurones inhibit the growth axis, whereas Arc growth hormone-releasing hormone (GHRH) neurones are stimulatory. Therefore, specific hypothalamic expression of somatostatin, NPY and GHRH was measured using quantitative in situ hybridisation.
Results:
Obese Ay/a mice were significantly heavier and longer than WT controls. Plasma IGFI concentrations were 30% greater in obese Ay/a mice. Obese Ay /a mice were hyperinsulinaemic and hyperleptinaemic, yet plasma ghrelin, and stomach ghrelin peptide and mRNA were significantly reduced. In obese Ay/a mice, PeVN somatostatin and Arc NPY mRNA expression were reduced by 50% compared to WT controls, whereas Arc GHRH mRNA expression was unchanged.
Conclusion:
Increased body length in adult obese Ay/a mice may result from reduced Arc NPY and PeVN somatostatin mRNA expression, which in turn, may increase plasma IGFI concentrations and upregulate the somatotrophic axis.
Keywords:
growth, melanocortin, agouti, ghrelin, leptin
Abbreviations:
Ay/a mouse, agouti mouse; IGFI, insulin-like growth factor-I; PeVN, periventricular nucleus; Arc, arcuate nucleus; GHRH, growth hormone-releasing hormone; NPY, neuropeptide Y; AgRP, agouti-related protein;
-MSH, alpha melancoyte-stimulating hormone; POMC, pro-opiomelanocortin; CNS, central nervous system; GH, growth hormone; GHS-R, growth hormone secretagogue receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Ghrelin: An orexigenic and somatotrophic signal from the stomach
Nature Reviews Neuroscience Review (01 Aug 2001)
Nature Clinical Practice Endocrinology & Metabolism Review (01 Oct 2007)
Nature Clinical Practice Endocrinology & Metabolism Review (01 Oct 2007)
RESEARCH
Elevated plasma ghrelin levels in Prader?Willi syndrome
Nature Medicine Letters to Editor (01 Jul 2002)

